Kura Oncology Inc Revenue per Employee (KURA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Kura Oncology Inc   (NASDAQ: KURA)
 

Kura Oncology Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 36.54% in the second quarter 2026, year on year to cumulative value of $77 million, Kura Oncology Inc 's revenue per employee grew on a trailing twelve months basis to $ 297,019. The productivity of Kura Oncology Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 338 other companies have achieved higher revenue per employee. While Kura Oncology Inc 's total ranking has deteriorated compared to the previous quarter from 2105 to 2648. Kura Oncology Inc has 260 employees.


What is Sales per Employee Ratio?







KURA Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 36.54 % 29.47 % -67.83 % - -
Sales per Employee (TTM) $ 297,019 275,535 259,546 400,112 320,304
KURA's Total Ranking # 2648 # 2105 # 948 # 307 # 0
Seq. Revenue Change 14.28 % 5.36 % -16.45 % 35.73 % 8.36 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 139
Healthcare Sector # 339
Overall Market # 2648

Revenue per Employee Statistics
High Average Low
$ 400,112 $ 205,608 $ 523
(Sep 30 2025)   (Mar 31 2016)



Financial Statements
Kura Oncology Inc 's Revenue MRQ $ 21 Millions Visit KURA's Income Statement
Kura Oncology Inc 's Revenues TTM $ 77 Millions Visit KURA's aggregate revenue growth
What are KURA's Sales? Visit KURA's Sales by Segment




Other Ratios
Kura Oncology Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
KURA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for KURA's Competitors
Revenue per Employee for KURA's Suppliers
Revenue per Employee for KURA's Customers

You may also want to know
KURA's Sales Growth Rates KURA's Pe Price to earnings ratio KURA's Receivables Turnover Ratio KURA's Stock Quote
KURA's Net Income Growth Rates KURA's Ps Price to Sales ratio KURA's Sales per Employee KURA's Asset Turnover Ratio
KURA's Net Margin KURA's Pb Price to Book ratio KURA's Financial Strength Ratios KURA's Dividend Payout Ratio
Date modified: 2026-09-03T23:54:00+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Orthofix Medical Inc   519,217.45 $ 833.344  Million 1,605 
Lexicon Pharmaceuticals Inc   511,962.96 $ 41.469  Million 81 
Perrigo Company Plc  511,604.94 $ 4,144.000  Million 8,100 
Beone Medicines Ltd   510,686.50 $ 6,128.238  Million 12,000 
Elanco Animal Health Incorporated  507,070.71 $ 5,020.000  Million 9,900 
Alpha Pro Tech Ltd   505,723.58 $ 62.204  Million 123 
Angiodynamics Inc   502,731.01 $ 317.726  Million 632 
Zimmer Biomet Holdings Inc   500,517.65 $ 8,508.800  Million 17,000 
Biofrontera Inc   499,521.74 $ 45.956  Million 92 
Accuray Incorporated  495,467.24 $ 400.833  Million 809 
Resmed Inc   495,001.76 $ 5,628.170  Million 11,370 
Adaptive Biotechnologies Corporation  493,719.55 $ 308.081  Million 624 
Carlsmed Inc   491,787.40 $ 62.457  Million 127 
Viatris Inc   491,243.33 $ 14,737.300  Million 30,000 
Invivyd Inc   478,401.64 $ 58.365  Million 122 
Maravai Lifesciences Holdings Inc   477,898.85 $ 207.886  Million 435 
Moderna Inc   474,042.55 $ 2,228.000  Million 4,700 
Guardant Health Inc   472,108.94 $ 1,183.105  Million 2,506 
Neuropace Inc   471,866.03 $ 98.620  Million 209 
Skinhealth Systems Inc   471,817.29 $ 289.224  Million 613 
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 
Stryker Corp  461,375.00 $ 25,837.000  Million 56,000 
Atara Biotherapeutics Inc   460,857.14 $ 6.452  Million 14 
Glaukos Corp  457,066.73 $ 500.031  Million 1,094 
Treace Medical Concepts Inc   456,237.78 $ 205.307  Million 450 
Medpace Holdings Inc   448,756.13 $ 2,782.288  Million 6,200 
Sight Sciences Inc   448,123.66 $ 83.351  Million 186 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.